We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Opts To Fast Track Constipation Drug

Law360 (July 17, 2006, 12:00 AM EDT) -- Trying to accelerate the regulatory review process, the U.S. Food and Drug Administration has decided to fast-track Wyeth Pharmaceuticals and Progenics Pharmaceuticals’ application for a drug intended to treat postoperative gastrointestinal...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.